What is ISPC's current stock price?

ISPC (iSpecimen Inc.) is currently trading at $3.39 with a market cap of $470.7K.

What sector is iSpecimen Inc. in?

iSpecimen Inc. (ISPC) operates in the Healthcare sector, specifically in the Medical - Diagnostics & Research industry.

InvestLog

ISPC iSpecimen Inc.

Healthcare

$3.39+0.00%OpenMarket Cap: $470,742

As of 2026-05-26

Valuation

View Details

P/E (TTM)

—

PEG

—

P/B

0.01

P/S

0.47

EV/EBITDA

0.21

DCF Value

$-44.39

FCF Yield

-1358.3%

Div Yield

0.0%

Margins & Returns

Gross Margin

-29.6%

Operating Margin

-961.4%

Net Margin

-1080.7%

ROE

-584.7%

ROA

-168.0%

ROIC

-924.0%

Financials

View All

Period	Revenue	Net Income	EPS
Q1 null	$156.0K	$-2.3M	$—
Q4 null	$51.8K	$-5.0M	$—
FY null	$1.9M	$-10.5M	$—
Q3 null	$106.6K	$-2.8M	$—

Analyst Ratings

View All

Consensus

Buy

Target (Consensus)

$—

Target (Median)

$—

Target Range

$— - $—

0 Strong Buy1 Buy0 Hold0 Sell0 Strong Sell

Trading Activity

Insider Trades

View All

Lee Arphingdirector:

SellWed Nov 19

Liang Yuyingofficer

SellThu Jan 30

LIM ROBERT BRADLEYdirector, officer: Chief Executive Officer

SellFri Dec 13

Dhaliwal Avtardirector

SellMon Sep 30

Dhaliwal Avtardirector:

SellMon Sep 30

Company Info

Sector

Healthcare

Industry

Medical - Diagnostics & Research

Country

Exchange

—

Beta

1.75

iSpecimen Inc. provides technology that connects life science researchers who need human biofluids, tissues, and living cells for their research with biospecimens available in healthcare provider organizations worldwide. Its cloud-based technology enables scientists to search for specimens and patients across a network of hospitals, labs, biobanks, blood centers, and other healthcare organizations. The company develops and operates iSpecimen Marketplace, a proprietary online marketplace platform that connects medical researchers who need access to subjects, samples, and data with hospitals, laboratories, and other organizations who have access to them. It serves biopharmaceutical companies, in vitro diagnostic companies, and government/academic institutions. The company was incorporated in 2009 and is headquartered in Lexington, Massachusetts.

Peers